Regencell Bioscience Holdings Limited (RGC)
NASDAQ: RGC · Real-Time Price · USD
25.81
-0.57 (-2.16%)
Mar 19, 2026, 12:27 PM EDT - Market open
RGC Market Cap
RGC has a market cap or net worth of $12.76 billion as of March 19, 2026. Its market cap has increased by 24,110.87% in one year.
Market Cap
12.76B
Enterprise Value
12.78B
1-Year Change
24,110.87%
Ranking
Category
Stock Price
$25.81
Market Cap Chart
Since the IPO on July 16, 2021, RGC's market cap has increased from $120.10M to $12.76B, an increase of 10,526.78%. That is a compound annual growth rate of 171.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 11.36B | 9.38% |
| Dec 31, 2025 | 10.38B | 16,053.85% |
| Dec 31, 2024 | 64.28M | -52.95% |
| Dec 29, 2023 | 136.63M | -62.35% |
| Dec 29, 2022 | 362.93M | -12.12% |
| Dec 31, 2021 | 413.00M | 243.88% |
| Jul 16, 2021 | 120.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 33.87B |
| United Therapeutics | 23.42B |
| Viatris | 15.56B |
| Neurocrine Biosciences | 13.03B |
| Dr. Reddy's Laboratories | 11.70B |
| Elanco Animal Health | 11.63B |
| Hims & Hers Health | 5.67B |
| Lantheus Holdings | 5.07B |